Sune Boris Nygård

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

Niels F. Jensen, Jan Stenvang, Mette K. Beck et al. · Molecular Oncology · 2015 · 139 citations · Full text

Medicine, Cancer Biology, Oncology +16

Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity

Martin Friedrichsen, Lars Endahl, Frederik Flindt Kreiner et al. · Molecular Metabolism · 2023 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification

Line Schmidt Tarpgaard, Camilla Qvortrup, Sune Boris Nygård et al. · BMC Cancer · 2016 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Topoisomerase‐1 and ‐2A gene copy numbers are elevated in mismatch repair‐proficient colorectal cancers

Ida Marie Heeholm Sønderstrup, Sune Boris Nygård, Tim Svenstrup Poulsen et al. · Molecular Oncology · 2015 · 26 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort

David H Smith, Ib Jarle Christensen, Niels F. Jensen et al. · PLoS ONE · 2013 · 24 citations · Full text

Medicine, Genetics, Oncology +15